Anabolin LA Interactions
There are 88 drugs known to interact with Anabolin LA (nandrolone), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, and 77 are moderate.
- View all 88 medications that may interact with Anabolin LA
- View Anabolin LA alcohol/food interactions (1)
- View Anabolin LA disease interactions (10)
Most frequently checked interactions
View interaction reports for Anabolin LA (nandrolone) and the medicines listed below.
- Accidental First Aid Supplies Paracetamol (acetaminophen)
- Accidental First Aid Supplies Paracetamol (acetaminophen)
- acetaminophen / codeine
- acetaminophen / codeine
- Adderall (amphetamine / dextroamphetamine)
- Adderall (amphetamine / dextroamphetamine)
- Adipex-P (phentermine)
- Adipex-P (phentermine)
- Adrenalin (epinephrine)
- Adrenalin (epinephrine)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- alprazolam
- Ambien (zolpidem)
- Ambien (zolpidem)
- diazepam
- diazepam
- Effexor (venlafaxine)
- Effexor (venlafaxine)
- Lyrica (pregabalin)
- Lyrica (pregabalin)
- oxazepam
- oxazepam
- Ritalin LA (methylphenidate)
- Ritalin LA (methylphenidate)
- tramadol
- tramadol
- Xanax (alprazolam)
- Xanax (alprazolam)
Anabolin LA alcohol/food interactions
There is 1 alcohol/food interaction with Anabolin LA (nandrolone).
Anabolin LA disease interactions
There are 10 disease interactions with Anabolin LA (nandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- diabetes
- hypercalcemia
- thyroid function tests
Report options
More about Anabolin LA (nandrolone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
FeroSul
FeroSul is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Infed
Infed is used for anemia due to chronic kidney disease, iron deficiency anemia
Aranesp
Aranesp (darbepoetin alfa) is used to treat anemia - a lack of red blood cells in the body ...
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.